Literature DB >> 22941766

Psoriasis, psoriatic arthritis and increased risk of incident Crohn's disease in US women.

Wen-Qing Li1, Jia-Li Han, Andrew T Chan, Abrar A Qureshi.   

Abstract

OBJECTIVE: Inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), shares clinical and immunological features with psoriasis. Genome-wide association studies have found common susceptibility genes. However, epidemiologic data evaluating the association between psoriasis, psoriatic arthritis and risk of IBD are sparse. We aimed to evaluate the association between psoriasis, psoriatic arthritis and incident CD and UC among women in the USA.
METHODS: 174 476 women were enrolled in the Nurses' Health Study (NHS) (1996-2008) and NHS II (1991-2007). Lifetime history of physician-diagnosed psoriasis and psoriatic arthritis was confirmed by supplementary questionnaires. Information on CD and UC was obtained by self-reported questionnaires and confirmed by medical record review.
RESULTS: We documented 188 incident cases of CD and 240 incident cases of UC during follow-up. Psoriasis was associated with a significantly increased risk of subsequent CD with a multivariate-adjusted relative risk (RR) of 4.00 (95% CI 1.72 to 9.27) for NHS and 3.76 (1.82 to 7.74) for NHS II. By contrast, we did not observe a significant increase in risk of UC associated with psoriasis. In a pooled analysis of both cohorts, women with psoriasis experienced a significantly increased risk of CD (RR, 3.86, 95% CI 2.23 to 6.67), but not UC (RR, 1.17, 95% CI 0.41 to 3.36). The risk of CD was especially pronounced among psoriatics with concomitant psoriatic arthritis (RR, 6.43, 95% CI 2.04 to 20.32).
CONCLUSIONS: Psoriasis with concomitant psoriatic arthritis is associated with an increased risk of incident CD.

Entities:  

Keywords:  Epidemiology; Outcomes research; Psoriatic Arthritis

Mesh:

Year:  2012        PMID: 22941766      PMCID: PMC3547138          DOI: 10.1136/annrheumdis-2012-202143

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  45 in total

1.  Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences.

Authors:  Edward V Loftus
Journal:  Gastroenterology       Date:  2004-05       Impact factor: 22.682

2.  A genome-wide association study identifies IL23R as an inflammatory bowel disease gene.

Authors:  Richard H Duerr; Kent D Taylor; Steven R Brant; John D Rioux; Mark S Silverberg; Mark J Daly; A Hillary Steinhart; Clara Abraham; Miguel Regueiro; Anne Griffiths; Themistocles Dassopoulos; Alain Bitton; Huiying Yang; Stephan Targan; Lisa Wu Datta; Emily O Kistner; L Philip Schumm; Annette T Lee; Peter K Gregersen; M Michael Barmada; Jerome I Rotter; Dan L Nicolae; Judy H Cho
Journal:  Science       Date:  2006-10-26       Impact factor: 47.728

Review 3.  Inflammatory bowel disease: clinical aspects and established and evolving therapies.

Authors:  Daniel C Baumgart; William J Sandborn
Journal:  Lancet       Date:  2007-05-12       Impact factor: 79.321

Review 4.  Inflammatory bowel disease: cause and immunobiology.

Authors:  Daniel C Baumgart; Simon R Carding
Journal:  Lancet       Date:  2007-05-12       Impact factor: 79.321

5.  The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study.

Authors:  Charles N Bernstein; Andre Wajda; James F Blanchard
Journal:  Gastroenterology       Date:  2005-09       Impact factor: 22.682

6.  Further evidence for an association between psoriasis, Crohn's disease and ulcerative colitis.

Authors:  V M Yates; G Watkinson; A Kelman
Journal:  Br J Dermatol       Date:  1982-03       Impact factor: 9.302

7.  Microscopic inflammatory changes in colon of patients with both active psoriasis and psoriatic arthritis without bowel symptoms.

Authors:  R Scarpa; F Manguso; A D'Arienzo; F P D'Armiento; C Astarita; G Mazzacca; F Ayala
Journal:  J Rheumatol       Date:  2000-05       Impact factor: 4.666

8.  Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction.

Authors:  Robert S Stern; Tamar Nijsten; Steven R Feldman; David J Margolis; Tara Rolstad
Journal:  J Investig Dermatol Symp Proc       Date:  2004-03

9.  Psoriasis, psoriatic arthritis, or psoriatic disease?

Authors:  Raffaele Scarpa; Fabio Ayala; Nicola Caporaso; Ignazio Olivieri
Journal:  J Rheumatol       Date:  2006-02       Impact factor: 4.666

10.  Increased occurrence of psoriasis in patients with Crohn's disease and their relatives.

Authors:  F I Lee; S V Bellary; C Francis
Journal:  Am J Gastroenterol       Date:  1990-08       Impact factor: 10.864

View more
  53 in total

Review 1.  The Epidemiology of Psoriatic Arthritis.

Authors:  Alexis Ogdie; Pamela Weiss
Journal:  Rheum Dis Clin North Am       Date:  2015-09-11       Impact factor: 2.670

2.  Rosacea, Use of Tetracycline, and Risk of Incident Inflammatory Bowel Disease in Women.

Authors:  Wen-Qing Li; Eunyoung Cho; Hamed Khalili; Shaowei Wu; Andrew T Chan; Abrar A Qureshi
Journal:  Clin Gastroenterol Hepatol       Date:  2015-09-25       Impact factor: 11.382

3.  The impact of co-existing immune-mediated diseases on phenotype and outcomes in inflammatory bowel diseases.

Authors:  G Conway; G Velonias; E Andrews; J J Garber; V Yajnik; A N Ananthakrishnan
Journal:  Aliment Pharmacol Ther       Date:  2017-01-20       Impact factor: 8.171

Review 4.  [Cutaneous involvement in chronic inflammatory bowel disease : Crohn's disease and ulcerative colitis].

Authors:  L Richter; K Rappersberger
Journal:  Hautarzt       Date:  2016-12       Impact factor: 0.751

Review 5.  [Differential diagnostic spectrum of psoriasis vs. psoriatic arthritis in skin and joints].

Authors:  S Gerdes; U Mrowietz; U Wagner
Journal:  Z Rheumatol       Date:  2017-08       Impact factor: 1.372

6.  Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease.

Authors:  Jose U Scher; Carles Ubeda; Alejandro Artacho; Mukundan Attur; Sandrine Isaac; Soumya M Reddy; Shoshana Marmon; Andrea Neimann; Samuel Brusca; Tejas Patel; Julia Manasson; Eric G Pamer; Dan R Littman; Steven B Abramson
Journal:  Arthritis Rheumatol       Date:  2015-01       Impact factor: 10.995

7.  Extra-articular manifestations in psoriatic arthritis patients.

Authors:  Rosario Peluso; Salvatore Iervolino; Maria Vitiello; Vincenzo Bruner; Gelsy Lupoli; Matteo Nicola Dario Di Minno
Journal:  Clin Rheumatol       Date:  2014-05-08       Impact factor: 2.980

8.  NOD2 expression is regulated by microRNAs in colonic epithelial HCT116 cells.

Authors:  Alice Y Chuang; Jim C Chuang; Zili Zhai; Feng Wu; John H Kwon
Journal:  Inflamm Bowel Dis       Date:  2014-01       Impact factor: 5.325

Review 9.  Epidemiological Assessments of Skin Outcomes in the Nurses' Health Studies.

Authors:  Wen-Qing Li; Eunyoung Cho; Martin A Weinstock; Hasan Mashfiq; Abrar A Qureshi
Journal:  Am J Public Health       Date:  2016-07-26       Impact factor: 9.308

10.  Incidence of Spondyloarthropathy in patients with ulcerative colitis: a population-based study.

Authors:  Raina Shivashankar; Edward V Loftus; William J Tremaine; W Scott Harmsen; Alan R Zinsmeister; Eric L Matteson
Journal:  J Rheumatol       Date:  2013-05-15       Impact factor: 4.666

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.